Trade Summary

6 days ago, Treace John T., serving as Chief Executive Officer at TREACE MEDICAL CONCEPTS, INC. (TMCI), purchased 24,606 shares at $4.03 per share, for a total transaction value of $99,195.55. Following this transaction, Treace John T. now holds 7,348,439 shares of TMCI.

This purchase represents a 0.34% increase in Treace John T.'s stake in the company.

The trade was executed on Wednesday, June 10, 2026 and publicly disclosed via SEC Form 4 filing on Friday, June 12, 2026 at 9:26 AM ET, 2 days after the trade was made.

TREACE MEDICAL CONCEPTS, INC. operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.